Approval · Notice of Compliance 17897 · 2016
VELCADE: Notice of Compliance 17897
Issued March 18, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17897
- Date
- March 18, 2016
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the outer label, inner label, product monograph and package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELCADE | Not yet assigned | — |
Medicinal ingredients
- BORTEZOMIB MANNITOL BORONIC ESTER 3.5 MG per VIAL